Ads
related to: did pfizer cut dividend
Search results
Results From The WOW.Com Content Network
High dividend yields can represent a lack of trust in a company's ability to afford dividends. However, the rising dividend yield seems to be just a byproduct of the market selling Pfizer stock ...
Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield -- the highest among major drug manufacturers and one of the ...
Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable at first glance. ... The 10 stocks that made the cut ...
Collecting an above-average dividend payment can sometimes come with risks. High-yielding stocks can be due for cuts to their payouts if a company's underlying financials aren't strong enough to ...
With a lot of new drugs to sell, Pfizer expects adjusted earnings to reach a range between $2.15 and $2.35 per share this year, which is more than it needs to meet a dividend commitment currently ...
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
Pfizer: 6.48% yield The third ultra-high-yield dividend stock that makes for a screaming buy in 2025 is pharmaceutical goliath Pfizer (NYSE: PFE) , which is paying out a sustainable 6.5% yield.
The drugmaker has been paying dividends consistently for over 85 years and has a five year dividend growth rate of 2.5%. It offers a dividend yield of around 6.1% at current levels, which is well ...